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Hepatitis C: Screening and Education: Executive Summary 
Introduction of the Problem 
Hepatitis C Virus (HCV) is classified as a contagious liver disease that can be either 
acute or chronic, and the illness ranges in severity from mild to lifelong (CDC, 2016).  It is 
estimated that 2.7 million people in the United States (US) have HCV, but only half are 
diagnosed (Fujie, 2015). Based on the current Centers for Disease Control (CDC) guidelines, it is 
now recommended to screen everyone in the birth-cohort of 1945 to 1965 for HCV, regardless of 
symptoms or risk factors (CDC, 2016).  Despite this sweeping change in the CDC guidelines, 
screening for HCV remains low and the number of people living undiagnosed with HCV 
continues to grow (CDC, 2016). The goal of this project was to increase knowledge regarding 
the need for routine HCV screening at primary care clinics within a midwestern hospital. 
Through increased screening, it is anticipated the number of patients referred to the attached 
HCV clinic would increase and the patients living with HCV could subsequently be treated 
and/or cured.   
Literature Review  
As of 2017, about 75% of all HCV infections occur in adults in the birth cohort born 
between 1945 and 1965 (American Association for the Study of Liver Diseases [AASLD], 
2017). McGarry et al. (2012) estimated that up to 1.6 million people in the baby boomer 
generation are currently living undiagnosed with HCV. Of the individuals with acute HCV, 75% 
to 80% will develop chronic HCV (Ward, 2013). If chronic HCV infection is left untreated, it 
will lead to cirrhosis in 15-35% of patients, and 1%-3% will develop hepatocellular carcinoma 
(Ward, 2013).  By identifying these individuals with routine HCV screening and providing 
access to treatment, quality and longevity may be added to their lives (AASLD, 2017).   
   
 
   
 
Data from the National Health and Nutrition Examination Survey 2001–2008 (NHANES) 
showed only 3.7% of respondents were screened for HCV because neither the patient nor the 
doctor believed they were at risk for HCV (Falade-Nwulia et al, 2016). Causes of this low 
screening rate can be multifactorial, with the main influences including primary care providers’ 
limited knowledge about HCV screening recommendations, screening process, treatment, and 
incidence (Falade-Nwulia et al., 2016). 
A cost-effectiveness simulation by Rein et al. (2012) found that screening by birth cohort 
with a direct-acting antibody (DAA) tests, along with the standard treatment, increased the 
number of individuals screened for HCV, the amount of cases identified, and increased the 
number of people being treated versus the risk-based screening alone. McGarry et al. (2012) 
performed a cost-effectiveness simulation which determined that testing by birth cohort could 
result in a 25% decline in the amount of advanced liver disease and liver transplants associated 
with HCV.   
Clinical decision support systems (CDSS) can be used in various health care settings to 
improve patient care by incorporating evidence-based clinical information (Castaneda et al., 
2015). Properly equipped CDSS have shown to enhance patient care significantly by helping to 
diminish provider error and increase provider compliance with current health recommendations 
(Castaneda et al, 2015).  Clinical decision support systems, in the form of EHR pop-ups, can 
provide primary care providers with an opportunity to pause and review updated guidelines in a 
quick and efficient manner (Castaneda et al, 2015).  
Project Methods 
The purpose of this project was to increase awareness of the CDC screening guidelines 
for HCV in the birth cohort 1945 to 1965. A second purpose was to increase the Hepatitis C 
   
 
   
 
clinic utilization at a Midwestern hospital and to link the identified patients with HCV and 
subsequently increase referrals from primary care offices affiliated with this hospital. The final 
purpose of this project was to disseminate information to newly diagnosed patients with HCV in 
hospital’s community regarding treatment options and local resources, including the hospital 
affiliated HCV clinic.  Initially, the project authors planned to meet these goals through 
implementing a clinical decision support (CDSS) for nurses, medical assistants, and office staff 
in the hospital-specific electronic medical record (EMR) system.  With an increase in the overall 
screening for HCV in the primary care clinics of this hospital, it was anticipated that the number 
of patients referred to the hospital-based hepatitis clinic would increase as the patients presented 
for treatment and/or cures. This project was IRB exempt and classified as quality improvement 
within the organization. 
Evaluation 
While a CDSS was not possible to establish, in-services by clinic educators on the topic 
of HCV screening guidelines for the disease were performed.  Following these in-services, 
primary care office staff focus groups were conducted to assess understanding and application of 
the education. The success of the educational program presented to the primary care clinics 
associated with the hospital was measured through focus groups. The focus groups were used to 
assess knowledge regarding the importance of screening for HCV in the birth cohort 1945 to 
1965. All medical assistants and nurses were able to identify the birth cohort 1945 to 1965 when 
asked as well as the need for screening for HCV.  Education about HCV, the hospital-based 
HCV clinic, and current treatments was placed in local health departments and shared with the 
Red Cross. The measures for evaluation include HCV screening totals for this Midwestern 
hospital, hospital-based HCV clinic referrals, and HCV clinic patients per clinic day. Regarding 
   
 
   
 
the hospital-based HCV clinic utilization, the increase in patients seen from six months prior to 
implementation compared to the three months following implementation was 48%.  An increase 
in the in-network referrals over the same timeframe was 18%, from 58% prior to implementation 
to 76% post-implementation.  
Some of the barriers of the project included limited provider time, CDSS was not 
implemented because of both disinterest by the providers and resistance from the hospital -based 
charting system support team, limited communication between the medical assistant and the 
provider to obtain the order to screen the patient, and no standing orders exist for screening for 
hepatitis C.  There were also barriers to implement sharing of HCV resource information through 
the American Red Cross due to workflow issues that did not allow for region-specific 
information to be sent out to newly diagnosed patients  
Impact on Practice 
The immediate impact on clinical practice at this Midwestern hospital was seen through 
increased HCV screening, increased clinic utilization, and increased referrals to the HCV clinic 
for treatment. Additional impacts include increased awareness for the need for screening for 
HCV in the birth cohort 1945 to 1965 and treatment options at the hospital-based HCV clinic. 
The long-term impact of this project includes increased access to hospital-based 
resources through local health department, increased screening at the hospital-based primary care 
clinics, increased referrals to the hospital-based HCV clinic, and increased treatment of patients 
in this Midwestern city. 
For ongoing implementation, the project leaders recommend expanding this project to 
additional hospitals with hospital-based HCV clinics. Ongoing education is recommended for 
employees of hospital-based primary care clinics. Future research could explore connecting 
   
 
   
 
people who are newly diagnosed with HCV with local resources. The authors recommend 
extending this education to local clinics with high-risk clients such as methadone clinics, needle 
exchange programs, and Planned Parenthood as well as clinics that provide care for baby 
boomers. 
Conclusions 
After reviewing the literature and meeting with the staff, it is still recommended that the 
CDSS is implemented for the medical assistants and nurses in the primary care setting. It is also 
recommended that ongoing training and education is implemented for registered nurses and 
medical assistants on the necessity of HCV screening and the treatment options available to 
patients in our area.  Education and ongoing training should also be implemented at other 
hospitals and medical offices to increase HCV screening and subsequent treatment. 
Despite the unforeseen EPIC complications, wherein the CDSS for the nurses and 
medical assistants was not implemented, the clinic was still able to have an increase in the 
number of patients seen daily.  It is noted that the increase happened in congruence with the 
teaching about HCV screening that took place with the medical assistants and nurses.  The 
number of patients that the clinic was seeing from outside of the hospital did not increase.  While 
inversely, the number of patients that clinic providers were seeing from inside the hospital 
increased by almost 50%.  The clinics that referred patients to the HCV clinic were those that 
received the teaching.  
It is important that providers are aware of both the CDC and AASLD guidelines, which 
recommend testing for HCV by birth cohort and risk factors (AASLD, 2017; CDC, 2016). 
Following these recommendations has been demonstrated in the literature to be cost effective, 
   
 
   
 
improve screening rates, improve treatment, and prevent co-morbidities (Burstow et al., 2017; 
Coffin, Scott, Golden, & Sullivan, 2012; McEwan et al., 2013). 
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